Framework and Strategies to Eliminate Disparities in Colorectal Cancer Screening Outcomes.

Annual Review of Medicine
Chyke A DoubeniSamir Gupta

Abstract

Preventable differences in colorectal cancer (CRC) mortality across racial/ethnic, economic, geographic, and other groups can be eliminated by assuring equitable access and quality across the care continuum, but few interventions have been demonstrated to do so. Multicomponent strategies designed with a health equity framework may be effective. A health equity framework takes into account social determinants of health, multilevel influences (policy, community, delivery, and individual levels), screening processes, and community engagement. Effective strategies for increasing screening uptake include patient navigation and other interventions for structural barriers, reminders and clinical decision support, and data to continuously track metrics and guide targets for improvement. Community resource gaps should be addressed to assure high-quality services irrespective of racial/ethnic and socioeconomic status. One model combinespopulation-based proactive outreach screening with screening delivery at in-person or virtual points of contact, as well as community engagement. Patient- and provider-based behavioral interventions may be considered for increasing screening demand and delivery. Providing a choice of screening tests is rec...Continue Reading

References

Sep 1, 1988·The New England Journal of Medicine·B VogelsteinJ L Bos
May 1, 1995·Health Education Quarterly·V J StrecherD W Bulger
Apr 6, 2004·CA: a Cancer Journal for Clinicians·Harold P Freeman
Sep 8, 2007·BMJ : British Medical Journal·Alan Maryon-Davis
Dec 30, 2008·Journal of the National Medical Association·Rebecca L SiegelElizabeth M Ward
Feb 25, 2009·Archives of Internal Medicine·Thomas D SequistJohn Z Ayanian
Jul 23, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Chyke A DoubeniRobert H Fletcher
Apr 2, 2010·Journal of the National Cancer Institute·Adeyinka O LaiyemoChristine D Berg
Apr 2, 2010·Journal of the National Cancer Institute·John Z Ayanian
Apr 23, 2010·American Journal of Preventive Medicine·Resa M JonesSteven H Woolf
Oct 1, 2010·The New England Journal of Medicine·Howard K Koh, Kathleen G Sebelius
Jun 16, 2011·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Karen M KuntzAnn G Zauber
Jun 29, 2011·Epidemiologic Reviews·Theodore R LevinCindy Caldwell
Aug 4, 2011·Cancer·Harold P Freeman, Rian L Rodriguez
Apr 20, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Iris Lansdorp-VogelaarAhmedin Jemal
Sep 7, 2012·Journal of the National Cancer Institute·Chyke A DoubeniJeroan Allison
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen S GrubbsElectra D Paskett
Sep 18, 2013·JAMA Internal Medicine·Reena Gupta, Thomas Bodenheimer
Apr 1, 2014·Journal of the National Cancer Institute·Samir GuptaMaria Elena Martinez
Apr 4, 2014·The New England Journal of Medicine·Douglas A CorleyCharles P Quesenberry
Jun 12, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jasmin A TiroCarrie Klabunde
Feb 28, 2015·Annals of Epidemiology·Reinier G S MeesterAnn G Zauber
Jul 15, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rebecca L SiegelAhmedin Jemal
Nov 4, 2015·The American Journal of Gastroenterology·Peter S LiangJohn M Inadomi
Feb 5, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jessica ChubakUNKNOWN PROSPR consortium
Mar 27, 2016·Gastroenterology·Chyke A DoubeniAnn G Zauber
Apr 12, 2016·Annals of Internal Medicine·Kirsten Bibbins-Domingo, UNKNOWN U.S. Preventive Services Task Force
May 3, 2016·American Journal of Preventive Medicine·Anne Marie McCarthyUNKNOWN PROSPR consortium
Jun 16, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceAlbert L Siu
Dec 6, 2016·JAMA Internal Medicine·Chyke A Doubeni
Jan 25, 2017·JAMA : the Journal of the American Medical Association·Ali H MokdadChristopher J L Murray
Apr 27, 2017·JAMA : the Journal of the American Medical Association·Douglas A CorleyTheodore R Levin
May 23, 2017·Annals of Internal Medicine·Stacey A FedewaMichael Goodman

❮ Previous
Next ❯

Citations

May 20, 2021·American Society of Clinical Oncology Educational Book·Laura W MusselwhiteEdith P Mitchell
Nov 21, 2021·Digestive Diseases and Sciences·Caitlin C MurphyAmit G Singal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Primary Care & Community Health
Barcey T LevyYinghui Xu
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
K Robin YabroffStephen Taplin
© 2021 Meta ULC. All rights reserved